Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report ; volume:11 ; number:2 ; year:2021 ; pages:116-123 ; extent:8
Case reports in nephrology and dialysis ; 11, Heft 2 (2021), 116-123 (gesamt 8)
- Creator
-
Vissing-Uhre, Roald
Hansen, Alastair
Frevert, Susanne
Hansen, Ditte
- DOI
-
10.1159/000515644
- URN
-
urn:nbn:de:101:1-2021091600432225989696
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vissing-Uhre, Roald
- Hansen, Alastair
- Frevert, Susanne
- Hansen, Ditte
Other Objects (12)
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: Treatment outline and risk stratification
Perspectives in membranous nephropathy
Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
PLA2R-positive membranous nephropathy in IgG4-related disease
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Remission of Membranous Nephropathy after Treatment of Localised Prostate Cancer
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: Treatment outline and risk stratification
Perspectives in membranous nephropathy
Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
PLA2R-positive membranous nephropathy in IgG4-related disease
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Remission of Membranous Nephropathy after Treatment of Localised Prostate Cancer
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: Treatment outline and risk stratification
Perspectives in membranous nephropathy
Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
PLA2R-positive membranous nephropathy in IgG4-related disease
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Remission of Membranous Nephropathy after Treatment of Localised Prostate Cancer